

Dr Oseme Etomi
Dr Oseme Etomi is an obstetric physician in London, UK, and works across three National Health System (NHS) trusts including Guy’s and St Thomas’, King’s and the Queen Elizabeth NHS hospital trusts.
Her background is in rheumatology and general medicine and her main field of interest is in obstetric rheumatology, looking after women with inflammatory rheumatic diseases (IRDs) in pregnancy.
Dr Etomi was trained in some of London’s most prestigious rheumatology centres, including the Royal Free Hospital (National Centre for Scleroderma and Other Connective Tissue Disorders) and Barts Health NHS Trust and the Royal London Hospital (National Centre of Inflammatory Arthritis and Systemic Lupus Erythematosus).
In 2017, Dr Etomi undertook a clinical fellowship at St Thomas’ Hospital, and she now runs a weekly Rheumatic Disease in Pregnancy clinic, seeing patients with the whole spectrum of IRDs.
Dr Etomi has published numerous abstracts and papers on IRDs and pregnancy. In 2018, she was awarded the best oral presentation at the International Society of Obstetric Medicine (ISOM) for her work in this field.
Dr Etomi was instrumental in setting up the British Society of Rheumatology (BSR) Special Interest Group in Pregnancy in 2019. She sits on the advisory board for the Biologics in Rheumatoid Arthritis in Pregnancy (BiRAP) group and is currently one of the organisers of the 12th Rheumapreg Symposium in September 2023 in London.
Prof. Tzellos, Dr Martorell, Dr McGrath and Prof. Jemec detail HS treatment options, the role of imaging and the HCP-patient relationship
Prof. Christos Zouboulis and Dr Axel Villani kick-off the webinar series by explaining the fundamentals of the HS disease story and pathophysiology
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.